NCT04096534 (NORPN) is a NA clinical trial of Normotonic partial nephrectomy in Renal Malignant Tumor, sponsored by Saint Petersburg State University, Russia.

Who is sponsoring NCT04096534?

NCT04096534 is sponsored by Saint Petersburg State University, Russia.

What drugs are being tested in NCT04096534?

Interventions in NCT04096534: Normotonic partial nephrectomy, Hypotonic partial nephrectomy.

What condition does NCT04096534 study?

NCT04096534 studies Renal Malignant Tumor, Renal Tumor.

Is NCT04096534 still recruiting?

NCT04096534 is currently completed. Last updated 25 May 2022.

Last reviewed 2022-05-25 · How we verify

NCT04096534: NORPN

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Normotonic Partial Nephrectomy as Novel Approach in Treating Small Renal Masses

Completed NA Last updated 25 May 2022

What this trial tests

NA trial testing Normotonic partial nephrectomy in Renal Malignant Tumor in 108 participants. Completed in 7 May 2022.

Timeline

7 October 2019

Primary endpoint
7 May 2022

7 May 2022

Quick facts

Lead sponsor	Saint Petersburg State University, Russia
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	108
Start date	7 October 2019
Primary completion	7 May 2022
Estimated completion	7 May 2022
Sites	1 location across Russia

Drugs / interventions tested

Normotonic partial nephrectomy
Hypotonic partial nephrectomy

Conditions studied

Renal Malignant Tumor — all drugs for Renal Malignant Tumor →
Renal Tumor — all drugs for Renal Tumor →

Sponsor

Saint Petersburg State University, Russia

Who can join

Adults 18 to 85, any sex, with Renal Malignant Tumor or Renal Tumor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates novel surgical approach in treating small renal masses. Half of participants will undergo hypotonic zero-ischaemia partial nephrectomy (standard of care), while the other half will undergo normotonic zero-ischaemia partial nephrectomy (experimental method).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Saint Petersburg State University, Russia trials

Trials by the same sponsor.

NCT07116343 — Intrapleural Ropivacaine Infusion in Cardiac Surgery · Phase 4 · recruiting
NCT07185334 — Single-Stage Prepectoral Placement of Textured Implants Using a Polyester Mesh Endoprostheses With Fluoropolymer Coating · NA · active not recruiting
NCT07106112 — Carbon Suspension vs. Metallic Marker for Axillary Lymph Node Marking in Breast Cancer After Neoadjuvant Therapy · NA · recruiting
NCT06654401 — Electrical Cardioversion As a Predictor in Postoperative Preservation of Sinus Rhythm · NA · recruiting
NCT06626711 — Effect of Propofol and Sevoflurane Anesthesia on HSP70 Expression in Tumor Cells · EARLY_PHASE1 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04096534 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Saint Petersburg State University, Russia
Last refreshed: 25 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04096534.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing